| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $278.3M | -10.0% |
| R&D Expense | $49.6M | -3.4% |
| SG&A Expense | $56.5M | -4.0% |
| Operating Income | -$195.5M | -44.1% |
| Pre-tax Income | -$189.3M | -40.5% |
| Income Tax | $0 | — |
| Net Income | -$189.3M | -40.5% |
| EPS (Basic) | -$3.91 | -6.0% |
| EPS (Diluted) | -$3.91 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.6M | -28.6% |
| Accounts Receivable | $103.3M | -14.4% |
| Current Assets | $178.0M | -20.5% |
| Total Assets | $392.7M | -31.6% |
| Current Liabilities | $149.0M | -13.0% |
| Long-term Debt | $218.6M | -15.1% |
| Total Liabilities | $322.7M | -26.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.8M | -4669.7% |
| Capital Expenditures | $1.6M | +134.2% |
| Investing Cash Flow | -$18.7M | -86.3% |
| Financing Cash Flow | $1.4M | +107.2% |
| Free Cash Flow | -$10.4M | -1119.0% |
| -6.0% |
| Stockholders' Equity |
| $70.0M |
| -48.1% |